Parjeet Kaur

1.6k total citations · 1 hit paper
27 papers, 1.1k citations indexed

About

Parjeet Kaur is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Parjeet Kaur has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Parjeet Kaur's work include Vitamin D Research Studies (7 papers), Metabolism, Diabetes, and Cancer (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). Parjeet Kaur is often cited by papers focused on Vitamin D Research Studies (7 papers), Metabolism, Diabetes, and Cancer (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). Parjeet Kaur collaborates with scholars based in India. Parjeet Kaur's co-authors include Ambrish Mithal, Mohammad Shafi Kuchay, Sunil Kumar Mishra, Jasjeet Singh Wasir, Manish Kumar Singh, Narendra S. Choudhary, Khalid Farooqui, Sonal Krishan, Ambrish Mithal and Ganesh Jevalikar and has published in prestigious journals such as Diabetes Care, Diabetologia and Bone.

In The Last Decade

Parjeet Kaur

27 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)

2018 456 citations Mohammad Shafi Kuchay, Sonal Krishan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Parjeet Kaur India	14	585	583	295	234	194	27	1.1k
Mohammad Shafi Kuchay India	15	809 1.4×	910 1.6×	353 1.2×	259 1.1×	140 0.7×	53	1.6k
Luca Scala Italy	11	680 1.2×	1.3k 2.3×	268 0.9×	109 0.5×	641 3.3×	11	1.7k
Yiting Xu China	17	246 0.4×	202 0.3×	68 0.2×	221 0.9×	104 0.5×	69	752
Marie‐Hélène Gannagé‐Yared Lebanon	15	243 0.4×	325 0.6×	145 0.5×	231 1.0×	629 3.2×	53	1.3k
Cristina Maglio Sweden	18	616 1.1×	645 1.1×	871 3.0×	188 0.8×	134 0.7×	41	1.8k
Kentaro Kohagura Japan	17	384 0.7×	150 0.3×	213 0.7×	167 0.7×	155 0.8×	56	1.1k
Sunil Kumar Mishra India	13	614 1.0×	762 1.3×	244 0.8×	181 0.8×	75 0.4×	24	1.1k
Vesa Savolainen Finland	21	147 0.3×	878 1.5×	1.0k 3.5×	148 0.6×	264 1.4×	29	1.7k
Sung Woo Park South Korea	16	382 0.7×	300 0.5×	138 0.5×	138 0.6×	79 0.4×	36	801
Anthony J. Donaghy Australia	12	228 0.4×	413 0.7×	272 0.9×	69 0.3×	42 0.2×	14	857

Countries citing papers authored by Parjeet Kaur

Since Specialization

Citations

This map shows the geographic impact of Parjeet Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parjeet Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parjeet Kaur more than expected).

Fields of papers citing papers by Parjeet Kaur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parjeet Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parjeet Kaur. The network helps show where Parjeet Kaur may publish in the future.

Co-authorship network of co-authors of Parjeet Kaur

This figure shows the co-authorship network connecting the top 25 collaborators of Parjeet Kaur. A scholar is included among the top collaborators of Parjeet Kaur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parjeet Kaur. Parjeet Kaur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kaur, Parjeet, et al.. (2024). mRNA expression of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic and asymptomatic primary hyperparathyroidism. European Journal of Endocrinology. 191(4). 457–462. 1 indexed citations

Kuchay, Mohammad Shafi, Mitali Mishra, Parjeet Kaur, et al.. (2023). Dapagliflozin for inpatient hyperglycemia in cardiac surgery patients with type 2 diabetes: randomised controlled trial (Dapa-Hospital trial). Acta Diabetologica. 60(11). 1481–1490. 5 indexed citations

Kuchay, Mohammad Shafi, José Ignacio Martínez‐Montoro, Parjeet Kaur, José Carlos Fernández‐García, & Bruno Ramos‐Molina. (2022). Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk. Ageing Research Reviews. 80. 101696–101696. 45 indexed citations

Kaur, Parjeet, et al.. (2021). Decreased handgrip strength in patients with type 2 diabetes: A cross-sectional study in a tertiary care hospital in north India. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 15(1). 325–329. 20 indexed citations

Jevalikar, Ganesh, et al.. (2021). Risk Factors for Cerebral Edema and Acute Kidney Injury in Children with Diabetic Ketoacidosis. Indian Journal of Critical Care Medicine. 25(12). 1446–1451. 10 indexed citations

Kuchay, Mohammad Shafi, et al.. (2021). Denosumab can be used successfully as a bridge to surgery in patients with severe hypercalcemia due to primary hyperparathyroidism. Archives of Endocrinology and Metabolism. 65(5). 669–673. 7 indexed citations

Bhattacharya, Saptarshi, et al.. (2020). Anticancer Drug-induced Thyroid Dysfunction. touchREVIEWS in Endocrinology. 16(1). 32–32. 31 indexed citations

Kaur, Parjeet, Ranjit Mohan Anjana, Nikhil Tandon, et al.. (2020). Increased prevalence of self-reported fractures in Asian Indians with diabetes: Results from the ICMR-INDIAB population based cross-sectional study. Bone. 135. 115323–115323. 5 indexed citations

Kuchay, Mohammad Shafi, Sonal Krishan, Sunil Kumar Mishra, et al.. (2020). Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial). Diabetologia. 63(11). 2434–2445. 169 indexed citations

10.

Kaur, Parjeet, et al.. (2019). Adverse effect profile and effectiveness of sodium glucose co-transporter 2 inhibitors (SGLT2i) - A prospective real-world setting study. Indian Journal of Endocrinology and Metabolism. 23(1). 50–50. 14 indexed citations

11.

Jevalikar, Ganesh, Beena Bansal, Sunil Kumar Mishra, et al.. (2016). Childhood and Youth Onset Diabetes: A Single Centre Experience. The Indian Journal of Pediatrics. 83(8). 792–798. 5 indexed citations

12.

Kaur, Parjeet, et al.. (2016). Impact of preoperative imaging on surgical approach for primary hyperparathyroidism: Data from single institution in India. Indian Journal of Endocrinology and Metabolism. 20(5). 625–625. 11 indexed citations

13.

Kaur, Parjeet, et al.. (2016). Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting. Indian Journal of Endocrinology and Metabolism. 20(5). 595–595. 7 indexed citations

14.

Kaur, Parjeet, et al.. (2014). Clinical experience with Liraglutide in 196 patients with type 2 diabetes from a tertiary care center in India. Indian Journal of Endocrinology and Metabolism. 18(1). 77–77. 13 indexed citations

15.

Mithal, Ambrish, et al.. (2014). Usage of pioglitazone at Medanta, the Medicity. Indian Journal of Endocrinology and Metabolism. 18(1). 111–111. 5 indexed citations

16.

Mithal, Ambrish, et al.. (2014). Vitamin D and insulin resistance in postmenopausal Indian women. Indian Journal of Endocrinology and Metabolism. 18(1). 89–89. 14 indexed citations

17.

Mithal, Ambrish, et al.. (2013). Effect of two different doses of oral cholecalciferol supplementation on serum 25-hydroxy-vitamin D levels in healthy Indian postmenopausal women: A randomized controlled trial. Indian Journal of Endocrinology and Metabolism. 17(5). 883–889. 21 indexed citations

18.

Mithal, Ambrish, Parjeet Kaur, Sanjay Kalra, et al.. (2012). Widespread vitamin D deficiency among Indian health care professionals. Archives of Osteoporosis. 7(1-2). 187–192. 51 indexed citations

19.

Mithal, Ambrish & Parjeet Kaur. (2012). Osteoporosis in Asia: A Call to Action. Current Osteoporosis Reports. 10(4). 245–247. 96 indexed citations

20.

Marwaha, R. K., Nikhil Tandon, Parjeet Kaur, et al.. (2011). Establishment of Age-Specified Bone Mineral Density Reference Range for Indian Females Using Dual-Energy X-Ray Absorptiometry. Journal of Clinical Densitometry. 15(2). 241–249. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact